We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · October 05, 2020

Association of Survival With Adjuvant Chemotherapy Among Patients With Early-Stage NSCLC Impacted by Tumor Size and High-Risk Clinicopathologic Features

JAMA Oncology

 

Additional Info

JAMA Oncology
Association of Survival With Adjuvant Chemotherapy Among Patients With Early-Stage Non-Small Cell Lung Cancer With vs Without High-Risk Clinicopathologic Features
JAMA Oncol 2020 Sep 17;[EPub Ahead of Print], R Pathak, SB Goldberg, M Canavan, J Herrin, JR Hoag, MC Salazar, M Papageorge, T Ermer, DJ Boffa

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading